Cells4Life Middle East

What Cells4Life Middle East does

Cells4Life Middle East, operating under the trading name MedCells, is a Dubai-based private healthcare services company founded in 2005 that provides umbilical cord blood stem cell banking to families in the UAE and broader Middle East. The company's core service is the collection of hematopoietic stem cells (HSCs) from umbilical cord blood immediately after birth, followed by processing and long-term cryogenic preservation for potential future medical use against blood disorders, certain cancers, immune system conditions, and metabolic disorders.

The company's product portfolio is intentionally narrow: a single core cord blood banking service with a stated capability set of more than 20 years of industry experience and 80+ treatable medical conditions (industry-wide figure of 85,000+ transplants cited). The underlying technical operation relies on specialized processing and cryogenic storage infrastructure needed to maintain stem cell viability over multi-decade storage horizons. The company holds no disclosed patents, certifications, or regulatory approvals in the source data, and operates without publicly disclosed pricing — customers are directed to contact the firm directly via phone (+971 4 3116613) or email ([email protected]).

Commercially, MedCells employs a direct-to-consumer go-to-market targeting expecting parents through educational content marketing on medcells.ae, leveraging the one-time-at-birth collection window as urgency. Revenue mechanics combine a one-time collection and processing fee with recurring annual storage subscriptions, creating long-duration annuity revenue per enrolled family. The company has 11-50 employees, no disclosed funding rounds, no parent company, no named management beyond the founder/Scientific Director role, and no disclosed M&A, partnerships, or expansion activity. It is a small, capital-efficient specialist operator in a niche consumer healthcare vertical.

Name

Cells4Life Middle East

Legal name

MedCells

Website

https://medcells.ae

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Cells4Life Middle East (trading as MedCells) is a Dubai-based cord blood stem cell banking service provider collecting, processing, and cryogenically storing umbilical cord blood for expecting families across the UAE and Middle East on a one-time-fee plus annual storage subscription model.

Ownership category

akta.pro rank

Product category

Cord Blood Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAAAGAE

Cell & Tissue Banking (biobanking, cord blood/tissue)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Cord blood banking
• Stem cell preservation
• Umbilical cord blood
• Hematopoietic stem cells
• Cryogenic biobanking

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Cord Blood Banking Services: One-time collection and processing fee combined with annual storage subscription. The service captures value at a single moment in time (birth) and generates recurring revenue through annual storage fees for the preserved stem cells over the lifetime of the customer.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Cells4Life Middle East, operating as MedCells, collects umbilical cord blood immediately after birth, processes it to isolate hematopoietic stem cells (HSCs), and stores the samples under long-term cryogenic conditions for potential future medical use. The service is sold directly to expecting parents as a one-time enrollment at birth with recurring annual storage fees. The company markets this as a biological insurance product for the child and family against 80+ treatable medical conditions including blood disorders, certain cancers, immune system and metabolic disorders.

Product overview

MedCells offers a single unified cord blood banking service focused on the collection, processing, and preservation of umbilical cord blood stem cells at the time of birth. The service provides families with a one-time opportunity to store hematopoietic stem cells that can be used in treatments for blood disorders, immune system conditions, and certain cancers. The product portfolio consists of this core banking service with no modular add-ons or separate product tiers described.

Differentiator

Problem solved

Functional benefit

Products and services

• Cord Blood Banking Service End-to-end service comprising collection of umbilical cord blood immediately after birth, laboratory processing to extract hematopoietic stem cells (HSCs), and long-term cryogenic storage designed to preserve cell viability over decades. Targeted at expecting parents and families seeking biological insurance for the child and family against blood disorders, certain cancers, immune system conditions, and metabolic disorders treatable with cord blood stem cells.

Quantifiable outcome

• 85,000+ successful transplants performed worldwide using cord blood stem cells
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves3 records

Expansion highlights2 records

Direct peers

• Cryo-Cell International: One of the largest private family cord blood banks globally, offering cord blood and cord tissue banking with long-term cryogenic storage. Directly comparable service mix and recurring storage model.
• StemCyte: Hybrid public/private cord blood bank offering both family and donor banking. Comparable cryopreservation infrastructure and storage service, with the addition of public banking operations.
• Cells4Life Group (UK): The UK-headquartered cord blood and tissue bank from which the Middle East entity appears to derive its branding. Operates the same core autologous cord blood and tissue storage service and is the most direct functional comparable.
• FamilyCord: U.S. private family cord blood and cord tissue bank with a recurring-storage revenue model and DTC marketing to expecting parents — closely aligned business model.
• ViaCord (Revvity): Family cord blood and cord tissue banking service within Revvity (formerly PerkinElmer), with established direct-to-consumer marketing to expecting parents. Closely comparable business model and clinical positioning.
• Smart Cells International: UK-based private cord blood and tissue stem cell bank serving international markets including the Middle East. Directly comparable storage service and similar DTC go-to-market approach.
• Future Health Biobank: UK-based private cord blood, cord tissue, and broader stem cell storage provider with international distribution including the Middle East. Directly comparable core service and DTC consumer model.

Emerging players

• Lifebank (Nigeria / emerging markets): Stem cell and cord blood banking service focused on emerging markets. Comparable service offering and consumer-facing positioning, though in a different geography.

Regional players

• Cryoviva (India / GCC presence): India-headquartered stem cell bank with active distribution across the Middle East and Southeast Asia. Comparable cord blood storage service and overlapping geographic footprint with MedCells in the GCC.

Broad incumbents

• Cord Blood Registry (CBR) by CooperSurgical: The largest U.S. family cord blood bank, now part of CooperSurgical. Comparable core service but with substantially larger scale, hospital integration, and broader reproductive-health portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/cells4lifeme
• Facebookfacebook.com/Cells4Life.MidEast
• LinkedInlinkedin.com/company/cells4lifeme

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cells4Life Middle East